Dodds Wealth’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
7,389
+38
+0.5% +$5.65K 0.26% 26
2026
Q1
$1.08M Sell
7,351
-30
-0.4% -$4.63K 0.26% 25
2025
Q4
$1.14M Sell
7,381
-2,029
-22% -$304K 0.28% 24
2025
Q3
$1.31M Buy
9,410
+62
+0.7% +$8.39K 0.32% 23
2025
Q2
$1.26M Sell
9,348
-375
-4% -$50.6K 0.34% 22
2025
Q1
$1.42M Sell
9,723
-10,131
-51% -$1.47M 0.46% 23
2024
Q4
$2.82M Sell
19,854
-794
-4% -$116K 0.91% 17
2024
Q3
$3.15M Buy
20,648
+911
+5% +$138K 1.05% 17
2024
Q2
$2.86M Sell
19,737
-775
-4% -$111K 1.12% 16
2024
Q1
$3.03M Buy
20,512
+1,736
+9% +$249K 1.23% 14
2023
Q4
$2.56M Buy
+18,776
New +$2.44M 1.31% 15

Other funds holding XLV

Dodds Wealth's XLV Position: Q2 2026 in Review

Dodds Wealth increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.52% in Q2 2026, buying an estimated $5.65K and bringing the position to 7,389 shares worth $1.17M. The position accounts for 0.26% of the portfolio, ranked #26.

Dodds Wealth first reported a position in XLV in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.15M in Q3 2024. 1,846 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Dodds Wealth held 7,389 shares of State Street Health Care Select Sector SPDR ETF worth $1.17M as of Q2 2026.
  • Dodds Wealth bought 38 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $5.65K.
  • State Street Health Care Select Sector SPDR ETF made up 0.26% of Dodds Wealth's portfolio in Q2 2026, its #26 holding.
  • Dodds Wealth first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2023 and has held it in 11 quarters since.
  • Dodds Wealth's State Street Health Care Select Sector SPDR ETF position peaked at $3.15M in Q3 2024.
  • 1,846 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Dodds Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.